COPD drugs is a medicine used to treatment chronic obstructive pulmonary disease, such as bronchodilators, pde-4 inhibitors, steroids, combination therapies, etc.
One of the emerging trends propelling the growth prospects for this market is the augmented focus and use of combination therapies to treat COPD. Combination therapies are increasingly becoming the preferred choice of treatment as they have better efficacy than monotherapy drugs.
The bronchodilators segment is one of the fastest growing segments of the COPD drugs market. Bronchodilators help relax bronchial muscles resulting in normal breathing. These drugs can be categorized into three types, namely beta-sympathomimetic, anticholinergics, and xanthine derivatives.
In 2017, the global COPD Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
This report focuses on the global top players, covered
Pfizer
Novartis
GlaxoSmithKline
Merck
Abbott Laboratories
Boehringer Ingelheim
AstraZeneca
Roche Holding AG
Teva Pharmaceutical Industries
Vectura Group
Mylan NV
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Market segment by Type, the product can be split into
Bronchodilators
PDE-4 Inhibitors
Steroids
Combination Therapies
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Request Sample Report and TOC@ http://www.qyresearchglobal.com/goods-1732590.html
About Us:
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.
Contact US
QY Research, INC.
Tina
17890 Castleton, Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: sales@qyrsearchglobal.com or tinaning@qyresearch.com
Web: www.qyresearchglobal.com
For other region, contact number given below
+86 108 294 5717 Beijing
+852 3062 8839 HK
